Author:
Garg Varun,Chandorkar Gurudatt,Farmer H. Frank,Smith Frances,Alves Katia,van Heeswijk Rolf P. G.
Subject
Pharmacology (medical),Pharmacology
Reference16 articles.
1. Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.4A serine protease;Lin;Infect Disord Drug Targets,2006
2. Telaprevir for previously untreated chronic hepatitis C virus infection;Jacobson;N Engl J Med,2011
3. Telaprevir in combination with peginterferon alfa-2a and ribavirin for 24 or 48 weeks in treatment-naïve genotype 1 HCV patients who achieved an extended rapid viral response: final results of Phase 3 ILLUMINATE study;Sherman;Hepatol,2010
4. Telaprevir for retreatment of HCV infection;Zeuzem;N Engl J Med,2011
5. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection;Hézode;N Engl J Med,2009
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献